ALDH1A2
ALDH1A2 (aldehyde dehydrogenase 1 family member A2, also known as RALDH2 or retinal dehydrogenase 2) is a cytoplasmic enzyme that catalyses the NAD-dependent oxidation of retinaldehyde to retinoic acid, a hormonal signalling molecule derived from vitamin A. Browse Assay Genie's current range of ALDH1A2 research reagents below, or read on for the biology behind the target.
ALDH1A2 catalyses the NAD-dependent oxidation of aldehyde substrates to their corresponding carboxylic acids. Its characteristic substrates are all-trans-retinal and all-trans-13,14-dihydroretinal, which are converted to all-trans-retinoate and all-trans-13,14-dihydroretinoate. The enzyme recognises retinal both in its free form and when bound to cellular retinol-binding protein. It can also metabolise octanal and decanal, but shows only very low activity with benzaldehyde, acetaldehyde and propanal, and no activity with citral.
Retinoate signalling is critical for the transcriptional control of many genes, and it is crucial for the initiation of meiosis in both males and females. Retinoic acid (RA), the active derivative of vitamin A (retinol), acts as a hormonal signalling molecule in developing and adult tissues. Studies of the similar mouse gene suggest that this enzyme and the cytochrome CYP26A1 together establish local embryonic retinoic acid levels, which facilitate posterior organ development and prevent spina bifida.
The ALDH1A2 gene encodes a member of the aldehyde dehydrogenase family, and HGNC places it in the aldehyde dehydrogenases gene group. Four transcript variants encoding distinct isoforms have been identified. The previous HGNC name was aldehyde dehydrogenase 1 family, member A2, and RALDH2 remains a widely used alias. Mouse and rat orthologues are both named Aldh1a2, which supports comparative work on retinoid biology in these species.
ALDH1A2 synthesises retinoic acid from retinaldehyde, making it a key enzyme for studying retinoid-dependent transcriptional control.
With CYP26A1, the enzyme sets local embryonic retinoic acid levels that support posterior organ development and help prevent spina bifida.
Retinoate signalling is crucial for the initiation of meiosis in both male and female germ cells.
Defined substrate preferences for retinal, octanal and decanal make ALDH1A2 a useful model for aldehyde dehydrogenase specificity.
ALDH1A2 catalyses the NAD-dependent oxidation of retinaldehyde to retinoic acid, the active derivative of vitamin A. It also converts all-trans-13,14-dihydroretinal to its acid. The retinoate produced controls the transcription of many genes and is crucial for the initiation of meiosis.
The protein is also called RALDH2 and retinal dehydrogenase 2 (UniProt). Its former HGNC name was aldehyde dehydrogenase 1 family, member A2. Four transcript variants encoding distinct isoforms have been identified, so literature and product descriptions may refer to different isoforms.
Mouse and rat each have an orthologue named Aldh1a2. Studies of the mouse gene indicate that, together with CYP26A1, it establishes embryonic retinoic acid levels that support posterior organ development and prevent spina bifida. Check the datasheet of any product for its validated reactivity.
Other aldehyde dehydrogenase family members involved in retinoid and aldehyde metabolism, with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt O94788; product specifications from Assay Genie datasheets.